… Presenter: Gerard Platenburg, CSO and co-founder, ProQR Therapeutics Date: Thursday, March 23 Abstract: … models. jeu 23/03/2023 - 00:00 - jeu 23/03/2023 - 23:59 ProQR Presentation at the RNA Editing Gordon Research …
The EFF is a growing multiple stakeholder platform for the exchange and sharing of insights and innovations to drive the future of clinical development in inherited retinal diseases. Organized by ProQR
ProQR to host a conference call to discuss the top-line results of the Phase 2/3 Illuminate clinical trial of investigational RNA therapy sepofarsen in CEP20-mediated LCA10.
ProQR shared additional analyses from the Phase 2/3 Illuminate trial of sepofarsen for LCA10 and provided an update on the company strategy. Management to host a conference call today at 8:00am EDT (14:00 CET).